HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frederick R Nelson Selected Research

2- methoxy- 3- (4- (2- (5- methyl- 2- phenyloxazol- 4- yl)ethoxy)phenyl)propanoic acid

5/2009The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frederick R Nelson Research Topics

Disease

2Alzheimer Disease (Alzheimer's Disease)
11/2012 - 03/2008
1Schizophrenia (Dementia Praecox)
07/2011
1Breast Neoplasms (Breast Cancer)
05/2009
1Amyloid Plaque
03/2008

Drug/Important Bio-Agent (IBA)

2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
11/2012 - 07/2011
1Prazosin (Minipress)FDA LinkGeneric
05/2009
1Proteins (Proteins, Gene)FDA Link
05/2009
1alvocidib (flavopiridol)IBA
05/2009
12- methoxy- 3- (4- (2- (5- methyl- 2- phenyloxazol- 4- yl)ethoxy)phenyl)propanoic acidIBA
05/2009
1Imatinib Mesylate (Gleevec)FDA Link
05/2009
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
05/2009
1Amyloid beta-PeptidesIBA
03/2008

Therapy/Procedure

1Therapeutics
11/2012